Weekly Watchlist and Review 10/15/23

Weekly Watchlist and Review

Hey, traders and market enthusiasts! Dive into our latest Weekend Watchlist and Review, brought to you straight from ALERTSANDNEWS.COM. Man, last week was wild! Let’s break it down:

If last week was a thrill ride, stocks were the main attraction. Good thing we had our scanners and alerts dialed in. I was going cross eyed with all the runners. TPST? It’s the stuff of legends, first pinged at .29 and then rocketing to 11.50. In my decade plus of experience trading and monitoring the markets. It the top daily runner I’ve ever seen, beats HKD DRYS and other prior monsters.  This week we had some monster overnight hold alerts, including ACXP ran 137% PRZO ran 40% Top momentum alerts were TPST first alert came at .29 before running to 11.50, one of the best one day runners I’ve ever seen in my decade plus of monitoring and trading the markets. HUBC was brought to the team early as well, we had a list ready to go from the Israeli conflict, this is where our research is superior and keep the team ahead of the game. So many runners this week, Winners everyday! 

Here at ALERTSANDNEWS.COM, our DNA is consistency and precision. From momentum plays to overnights, swings, options, and dividend picks – we’ve got the spectrum covered. But always remember: your own research and education come first. For those chasing top-tier alerts and insights? We’ve got your back. Just take a peek at our past week’s alerts – the screenshots say it all. And before I forget: snag a 10% discount on signup with the code AAN10. Ready to level up your trading game? We’re here for it. Join us!

Let’s start what to eye tomorrow, and the news over the weekend.

Heres the Gappers from Friday. Some big movers here, YGMZ massive move in after hours, no news there. Another penny that was pumped it looks like. SVVC LUCY ISUN also strong in after hours.  All pennies. 

IMUX Headline here today. Immunic Presents Data From Phase 1b Clinical Trial of IMU-856 in Celiac Disease at the United European Gastroenterology Week 2023, A few levels to monitor tomorrow. 

MREO: News here on saturday. Ultragenyx and Mereo BioPharma Announce Interim Phase 2 Data from Phase 2/3 Orbit Study Demonstrating Setrusumab (UX143) Significantly Reduced Fracture Rates in Patients with Osteogenesis Imperfecta (OI) Keep an eye on this one tomorrow. 

AMC: screening of “Taylor Swift: The Eras Tour” made some serious noise at the box offices, raking in an impressive estimated $95M-$97M in the US and Canada over the weekend, according to Reuters. AMC has been buzzing on our radar recently, making multiple appearances on the watchlist. With this kind of traction, it’s worth seeing if the momentum carries into the upcoming trading session. Definitely one to keep an eye on as the bell rings tomorrow.

Let’s go over the weekend headlines, there was a TON of headlines from individual stocks and so I’ll break it down in 2 sections. Lets start with stock news over the weekend.

  • ABBV AbbVie Announced SKYRIZI Vs STELARA Head-to-Head Study In Crohn’s Disease Met All Primary And Secondary Endpoints
  • AMZN Amazon Listed A Strange Job Opening, Leading To Speculations About The Company’s Real Intentions
  • MLTX MoonLake Immunotherapeutics announces the full dataset from its 24-week MIRA clinical trial, establishing the Nanobody® sonelokimab as a highly promising and differentiated therapeutic solution for Hidradenitis Suppurativa
  • COGT Cogent Biosciences Presents Preclinical Data Highlighting Precision Oncology Pipeline at the 2023 AACR-NCI-EORTC International Conference
  • PRLD Prelude Announces Multiple Clinical and Preclinical Poster Presentations at AACR-NCI-EORTC International Conference
  • BDTX Black Diamond Therapeutics Presents Dose Escalation Data Demonstrating Durable Responses in Patients with NSCLC from Phase 1 Trial of BDTX-153
  • VSTM Verastem Oncology Announces Initial Results of RAMP 203 Trial of Avutometinib and LUMAKRAS™ (sotorasib) in KRAS G12C-Mutant Non-Small Cell Lung Cancer
  • CHRS Coherus Announces Toripalimab Data at 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
  • PBYI Puma Biotechnology Announces Presentation of Findings from a Phase I/II Study of Alisertib and Pembrolizumab for Rb-Deficient Head and Neck Squamous Cell Carcinomas at the 2023 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Meeting
  • BMY U.S. Food and Drug Administration Approves Opdivo® (nivolumab) as Adjuvant Treatment for Eligible Patients with Completely Resected Stage IIB or Stage IIC Melanoma1
  • MANU British billionaire Jim Ratcliffe is in talks to acquire a minority stake of Manchester United in a deal that would value the globally renowned soccer club at more than $3.3 billion, according to people familiar with the matter.

Mostly war headlines, Continue to eye PRZO and oil plays due to this. 

  • JPMorgan Chase CEO Jamie Dimon Issues Stark Warning Amid Israel-Hamas War: ‘The Most Dangerous Time In Decades’
  • Iranian Foreign Minister: Iran will not remain an observer in this situation and has informed Israel via its allies if its crimes in Gaza continue tomorrow will be too late – Al Jazeera.
  • Ambassador to the US: Israel doesn’t want to reoccupy Gaza.
  • US Secretary of State Blinken: Rafah crossing between Egypt and Gaza will be reopened.
  • GOP’s Graham: US senators group will visit Saudi Arabia and Israel – NBC.
  • Hezbollah: We attacked 5 Israeli targets: al Manar TV.
  • Israeli soldiers responding with live fire on Lebanon border.
  • Hamas Armed Wing: We fired 20 rockets from Lebanon on two Israeli settlements north of occupied Palestine.
  • Israel Army: We’re preparing for land, sea and air attack on Gaza.
  • SEC won’t appeal grayscale bitcoin spot ETF ruling
  • US House Republicans choose Jordan as Speaker of the House
  • New Zealand’s opposition wins election as PM Chris Hipkins concedes defeat.
  • Iran sent a message to Israel today stressing that it does not want further escalation in the Hamas-Israel war, but that it will have to intervene if the Israeli operation in Gaza continues, two diplomatic sources said – Axios

News Coming:

By staying informed about the FDA decisions and other news. Investors, healthcare professionals, and patients can gauge the potential impact on the pharmaceutical industry, stock market, and patient care. These decisions can influence the market value of pharmaceutical companies. Let’s look at the news coming: 

Stock Ticker Company NameDecision DetailsEstimated Decision Date
MRKMerck & Co Inc.

FDA decision on Keytruda for the treatment of patients with resectable stage II, IIIA, or IIIB NSCLC in combination with platinum-containing chemotherapy as neoadjuvant treatment, and then continued as a single agent as adjuvant treatment.KRAS G12C-mutated non-small cell lung cancer to full approval

ARDXArdelyx, IncFDA decision on XPHOZAH for the control of serum phosphorus in adult patients with chronic kidney disease on dialysis who have had an inadequate response or intolerance to a phosphate binder therapy.10/17/2023
BHCBausch Health Companies Inc.

FDA decision on IDP 126 gel triple therapy for the treatment for acne vulgaris.


Biomarin Pharmaceutical Inc.

FDA decision to expand VOXZOGO use in children with achondroplasia under the age of 5.10/21/2023
REGNRegeneron PharmaceuticalsFDA decision on Dupixent for chronic spontaneous urticaria in adults and adolescents aged 12 years and older10/22/2023
CPRXCatalyst Pharmaceutical Partners Inc.FDA decision on Vamorolone for the treatment of Duchenne Muscular Dystrophy10/26/2023

Vertex Pharmaceuticals Inc.

FDA panel to review Exa-cel in the treatment of severe sickle cell disease10/31/2023

Let’s look at some oversold and/or highly shorted stocks. 

Understanding oversold and highly shorted stocks is crucial for traders and investors as it prepares them to seize potential opportunities. Oversold stocks might represent a bargain if they are undervalued due to excessive selling. Highly shorted stocks are poised for what’s called a short squeeze. A rapid price increase that can occur when short sellers scramble to cover their positions. By staying informed, investors can be better prepared to navigate the market.

CDT: Man, remember that buzz right after its IPO? Since then, CDT’s been taking a nose-dive. The RSI? Practically scraping the bottom. And let’s talk about that float – it’s super thin. So, we’re keeping a sharp eye on volume ratios. Definitely one to watch closely over the next few weeks.

ESLA: Man, this one’s taken some serious hits lately. With a float hovering around the 2.9M mark and not a ton of shorts in play, it’s catching my attention. That RSI? Scream worthy levels of oversold. We’re definitely keeping this one under the microscope.

CUTR: Back for a second week on our watchlist. This one’s been catching our eye. The RSI’s deep in the trenches and the MACD’s looking like it took a cliff dive. The float’s sitting around 18M, and get this – about 36% of it is shorted (According to one source). Watch the volume closely; a bounce could be in the cards.

HOFV: Here’s another that’s been making waves on our screens. That RSI? Deep in the basement. With its rapid descent, we’re keeping a close watch for any volume spike. Stay sharp and keep this one front and center on your watchlist.

Oversold beat up stocks to eye,


Economic Calendar and Futures.

MONDAY, OCT. 16     
8:30 amEmpire State manufacturing surveyOct. -61.9
10:30 amPhiladelphia Fed President Patrick Harker speaks    
4:30 pmPhiladelphia Fed President Patrick Harker speaks    
TUESDAY, OCT. 17     
8:30 amU.S. retail salesSept. 0.2%0.6%
8:30 amRetail sales minus autosSept. 0.3%0.6%
9:15 amIndustrial productionSept. 0.1%0.4%
9:15 amCapacity utilizationSept. 79.7%79.7%
10:30 amFed Gov. Michelle Bowman speaks    
10:00 amBusiness inventoriesAug. 0.3%0.0%
10:00 amHome builder confidence indexOct. 4445
10:45 amRichmond Fed President Tom Barkin speaks    
10:30 amMinneapolis Fed President Neel Kashkari speaks    
8:30 amHousing startsSept. 1.37 million1.28 million
8:30 amBuilding permitsSept. 1.45 million1.54 million
12 pmFed Gov. Chris Waller speaks    
12:30 pmNew York Fed President John Williams speaks    
2:00 pmFed Beige Book    
6:55 pmFed Gov. Lisa Cook speaks    
THURSDAY, OCT. 19     
8:30 amInitial jobless claimsOct. 14 210,000209,000
8:30 amPhiladelphia Fed manufacturing surveyOct. -6.8-13.5
10:00 amExisting home salesSept. 3.9 million4.04 million
10:00 amU.S. leading economic indicatorsSept. -0.4%-0.4%
12:00 pmFed Chairman Jerome Powell speaks    
1:20 pmChicago Fed President Austan Goolsbee speaks    
1:30 pmFed Vice-Chair for Banking Michael Barr speaks    
4:00 pmAtlanta Fed President Raphael Bostic speaks    
6:40 pmDallas Fed President Lorie Logan speaks    
FRIDAY, OCT. 20     
12:15 pmCleveland Fed President Loretta Mester speaks

The forthcoming week is loaded with significant economic indicators and speakers that could influence market sentiment. Kicking off on Monday, October 16th, market participants will be eyeing the Empire State manufacturing survey. A previous score of 1.9 sets the stage, but how will it fare this time around? Notably, Philadelphia Fed President Patrick Harker will be addressing the market twice on the same day. Come Tuesday, U.S. retail sales for September will be under the microscope. With the previous month’s numbers in mind, will we see a continuation or a shift in trends? Other key indicators include Industrial production and the Home builder confidence index for October. Throughout the day, several Federal Reserve voices, including Fed Govs. Michelle Bowman and Chris Waller, will be making their remarks.

Wednesday brings attention to housing, with housing starts and building permit numbers queued up for release. The middle of the week also sees a substantial lineup of Fed speakers, including New York Fed President John Williams and Fed Gov. Lisa Cook. By Thursday, the market will be keenly focusing on initial jobless claims for October 14th and the Philadelphia Fed manufacturing survey. As the week begins to close, Friday remains light on data but holds anticipation for remarks from Cleveland Fed President Loretta Mester.

All in all, this upcoming week promises a blend of vital data points and insights from several key figures in the Fed. Market participants will undoubtedly be on their toes, navigating through these updates.

As of 6:24 PM EDT, market futures are Green. For more targeted insights and timely alerts, make sure to check us out at alertsandnews.com Don’t forget to use the promo code AAN10 for 10% discount on all our packages. Getting the team the first mover advantage. Get informed first with your command center for the markets. Don’t let the next big opportunity pass you by! Join the team today!


The forum, blog, watchlist and chatrooms on the Site are comprised of customers and members (including, without limitation, moderators who are in the employ of Alerts and News) posting content and information. All such information and content is for informational purposes only and does not constitute advice or a recommendation by Alerts and News to enter into any securities transactions or engage in any of the financial strategies reflected on or suggested in forum, blog, watchlist and chatrooms (whether such data, content or information is posted by Alerts and News or otherwise). Customers and members may write about securities in which they have a financial or other interest, and performance data reflecting other customer’s or member’s holdings may include information about securities not held by Alerts and News or its directors, officers, shareholders, employees, agents or affiliates. As such, Alerts and News is not responsible for the accuracy of data, content or information or any performance data in any forum, blog, watchlist and chatrooms; and the accuracy of data, content or information or any performance data are not guaranteed, may not be current and should not be relied upon. Nothing in any forum, blog, watchlist and chatrooms is intended as, nor should you rely on it as, investment advice provided by Alerts and News or its directors, officers, shareholders, employees, agents or affiliates. AlertsAndNews receives cash compensation for referring potential clients to Benzinga LLC via advertisements placed on their website. AlertsAndNews’s opinions are their own.

Take your trading to the next step!

Try a trial – for less than a cup of coffee

Shopping Cart
Scroll to Top